nodes	percent_of_prediction	percent_of_DWPC	metapath
Oxaprozin—PTGS2—colon cancer	0.757	1	CbGaD
Oxaprozin—CYP2C9—Capecitabine—colon cancer	0.0386	0.628	CbGbCtD
Oxaprozin—CYP2C9—Fluorouracil—colon cancer	0.0229	0.372	CbGbCtD
Oxaprozin—PTGS1—endothelium—colon cancer	0.0013	0.0924	CbGeAlD
Oxaprozin—PTGS2—endothelium—colon cancer	0.00124	0.0883	CbGeAlD
Oxaprozin—PTGS1—blood vessel—colon cancer	0.0012	0.0852	CbGeAlD
Oxaprozin—PTGS2—blood vessel—colon cancer	0.00115	0.0815	CbGeAlD
Oxaprozin—PTGS2—gall bladder—colon cancer	0.00108	0.0767	CbGeAlD
Oxaprozin—Fenbufen—PTGS2—colon cancer	0.000755	0.29	CrCbGaD
Oxaprozin—PTGS2—embryo—colon cancer	0.000684	0.0486	CbGeAlD
Oxaprozin—Agranulocytosis—Fluorouracil—colon cancer	0.000622	0.00377	CcSEcCtD
Oxaprozin—Lethargy—Capecitabine—colon cancer	0.000617	0.00374	CcSEcCtD
Oxaprozin—Cystitis noninfective—Methotrexate—colon cancer	0.000606	0.00367	CcSEcCtD
Oxaprozin—Melaena—Methotrexate—colon cancer	0.000606	0.00367	CcSEcCtD
Oxaprozin—Gastrointestinal haemorrhage—Capecitabine—colon cancer	0.000605	0.00366	CcSEcCtD
Oxaprozin—Haemoglobin—Fluorouracil—colon cancer	0.000602	0.00364	CcSEcCtD
Oxaprozin—Cystitis—Methotrexate—colon cancer	0.000599	0.00363	CcSEcCtD
Oxaprozin—Haemorrhage—Fluorouracil—colon cancer	0.000599	0.00362	CcSEcCtD
Oxaprozin—PTGS1—epithelium—colon cancer	0.000584	0.0415	CbGeAlD
Oxaprozin—Aplastic anaemia—Methotrexate—colon cancer	0.000582	0.00353	CcSEcCtD
Oxaprozin—Alopecia—Vincristine—colon cancer	0.000567	0.00343	CcSEcCtD
Oxaprozin—Coma—Methotrexate—colon cancer	0.000567	0.00343	CcSEcCtD
Oxaprozin—PTGS1—smooth muscle tissue—colon cancer	0.000562	0.04	CbGeAlD
Oxaprozin—Ecchymosis—Methotrexate—colon cancer	0.000561	0.00339	CcSEcCtD
Oxaprozin—Urine output increased—Methotrexate—colon cancer	0.000561	0.00339	CcSEcCtD
Oxaprozin—Bladder pain—Methotrexate—colon cancer	0.000561	0.00339	CcSEcCtD
Oxaprozin—Arrhythmia—Irinotecan—colon cancer	0.000558	0.00338	CcSEcCtD
Oxaprozin—PTGS2—epithelium—colon cancer	0.000558	0.0397	CbGeAlD
Oxaprozin—Alopecia—Irinotecan—colon cancer	0.000552	0.00334	CcSEcCtD
Oxaprozin—Abdominal pain upper—Capecitabine—colon cancer	0.000552	0.00334	CcSEcCtD
Oxaprozin—Toxic epidermal necrolysis—Capecitabine—colon cancer	0.000545	0.0033	CcSEcCtD
Oxaprozin—PTGS1—renal system—colon cancer	0.000541	0.0385	CbGeAlD
Oxaprozin—Sepsis—Methotrexate—colon cancer	0.000538	0.00326	CcSEcCtD
Oxaprozin—PTGS2—smooth muscle tissue—colon cancer	0.000538	0.0382	CbGeAlD
Oxaprozin—Flatulence—Irinotecan—colon cancer	0.000536	0.00325	CcSEcCtD
Oxaprozin—Gastritis—Capecitabine—colon cancer	0.000535	0.00324	CcSEcCtD
Oxaprozin—Arrhythmia—Fluorouracil—colon cancer	0.000535	0.00324	CcSEcCtD
Oxaprozin—Alopecia—Fluorouracil—colon cancer	0.000529	0.0032	CcSEcCtD
Oxaprozin—Lymphadenopathy—Methotrexate—colon cancer	0.000528	0.00319	CcSEcCtD
Oxaprozin—Asthma—Capecitabine—colon cancer	0.000523	0.00316	CcSEcCtD
Oxaprozin—PTGS2—renal system—colon cancer	0.000518	0.0368	CbGeAlD
Oxaprozin—Anaemia—Vincristine—colon cancer	0.000516	0.00313	CcSEcCtD
Oxaprozin—Polyuria—Methotrexate—colon cancer	0.000513	0.0031	CcSEcCtD
Oxaprozin—Photosensitivity—Methotrexate—colon cancer	0.000513	0.0031	CcSEcCtD
Oxaprozin—Sweating increased—Capecitabine—colon cancer	0.000509	0.00308	CcSEcCtD
Oxaprozin—Ill-defined disorder—Irinotecan—colon cancer	0.000505	0.00306	CcSEcCtD
Oxaprozin—Anaemia—Irinotecan—colon cancer	0.000503	0.00304	CcSEcCtD
Oxaprozin—Vertigo—Vincristine—colon cancer	0.000502	0.00304	CcSEcCtD
Oxaprozin—Hepatic failure—Methotrexate—colon cancer	0.000501	0.00303	CcSEcCtD
Oxaprozin—Leukopenia—Vincristine—colon cancer	0.0005	0.00303	CcSEcCtD
Oxaprozin—Pancytopenia—Capecitabine—colon cancer	0.000496	0.00301	CcSEcCtD
Oxaprozin—Vision blurred—Fluorouracil—colon cancer	0.000491	0.00297	CcSEcCtD
Oxaprozin—Malaise—Irinotecan—colon cancer	0.000491	0.00297	CcSEcCtD
Oxaprozin—Vertigo—Irinotecan—colon cancer	0.000489	0.00296	CcSEcCtD
Oxaprozin—Dysuria—Capecitabine—colon cancer	0.000489	0.00296	CcSEcCtD
Oxaprozin—Syncope—Irinotecan—colon cancer	0.000488	0.00295	CcSEcCtD
Oxaprozin—Renal failure acute—Methotrexate—colon cancer	0.000488	0.00295	CcSEcCtD
Oxaprozin—Leukopenia—Irinotecan—colon cancer	0.000487	0.00295	CcSEcCtD
Oxaprozin—CYP2C9—digestive system—colon cancer	0.000486	0.0346	CbGeAlD
Oxaprozin—Convulsion—Vincristine—colon cancer	0.000484	0.00293	CcSEcCtD
Oxaprozin—Hypertension—Vincristine—colon cancer	0.000482	0.00292	CcSEcCtD
Oxaprozin—Anaemia—Fluorouracil—colon cancer	0.000482	0.00292	CcSEcCtD
Oxaprozin—Loss of consciousness—Irinotecan—colon cancer	0.000478	0.0029	CcSEcCtD
Oxaprozin—Dermatitis exfoliative—Methotrexate—colon cancer	0.000477	0.00289	CcSEcCtD
Oxaprozin—Photosensitivity reaction—Capecitabine—colon cancer	0.000477	0.00289	CcSEcCtD
Oxaprozin—Hyperglycaemia—Capecitabine—colon cancer	0.000471	0.00285	CcSEcCtD
Oxaprozin—Hypertension—Irinotecan—colon cancer	0.00047	0.00284	CcSEcCtD
Oxaprozin—Pneumonia—Capecitabine—colon cancer	0.000469	0.00284	CcSEcCtD
Oxaprozin—Leukopenia—Fluorouracil—colon cancer	0.000466	0.00282	CcSEcCtD
Oxaprozin—Anaphylactoid reaction—Methotrexate—colon cancer	0.000465	0.00282	CcSEcCtD
Oxaprozin—Stevens-Johnson syndrome—Capecitabine—colon cancer	0.000462	0.0028	CcSEcCtD
Oxaprozin—Acute coronary syndrome—Capecitabine—colon cancer	0.000459	0.00278	CcSEcCtD
Oxaprozin—Lethargy—Methotrexate—colon cancer	0.000459	0.00278	CcSEcCtD
Oxaprozin—Renal failure—Capecitabine—colon cancer	0.000458	0.00277	CcSEcCtD
Oxaprozin—Discomfort—Irinotecan—colon cancer	0.000458	0.00277	CcSEcCtD
Oxaprozin—Myocardial infarction—Capecitabine—colon cancer	0.000457	0.00277	CcSEcCtD
Oxaprozin—Anaphylactic shock—Vincristine—colon cancer	0.000456	0.00276	CcSEcCtD
Oxaprozin—Oedema—Vincristine—colon cancer	0.000456	0.00276	CcSEcCtD
Oxaprozin—Jaundice—Capecitabine—colon cancer	0.000454	0.00275	CcSEcCtD
Oxaprozin—Stomatitis—Capecitabine—colon cancer	0.000454	0.00275	CcSEcCtD
Oxaprozin—Infection—Vincristine—colon cancer	0.000453	0.00274	CcSEcCtD
Oxaprozin—Conjunctivitis—Capecitabine—colon cancer	0.000453	0.00274	CcSEcCtD
Oxaprozin—Convulsion—Fluorouracil—colon cancer	0.000452	0.00273	CcSEcCtD
Oxaprozin—Confusional state—Irinotecan—colon cancer	0.000448	0.00271	CcSEcCtD
Oxaprozin—Thrombocytopenia—Vincristine—colon cancer	0.000446	0.0027	CcSEcCtD
Oxaprozin—Haematuria—Capecitabine—colon cancer	0.000444	0.00269	CcSEcCtD
Oxaprozin—PTGS1—digestive system—colon cancer	0.000444	0.0316	CbGeAlD
Oxaprozin—Oedema—Irinotecan—colon cancer	0.000444	0.00269	CcSEcCtD
Oxaprozin—Anaphylactic shock—Irinotecan—colon cancer	0.000444	0.00269	CcSEcCtD
Oxaprozin—Infection—Irinotecan—colon cancer	0.000441	0.00267	CcSEcCtD
Oxaprozin—Hyperhidrosis—Vincristine—colon cancer	0.000441	0.00267	CcSEcCtD
Oxaprozin—Discomfort—Fluorouracil—colon cancer	0.000438	0.00265	CcSEcCtD
Oxaprozin—Shock—Irinotecan—colon cancer	0.000437	0.00265	CcSEcCtD
Oxaprozin—Agranulocytosis—Capecitabine—colon cancer	0.000435	0.00263	CcSEcCtD
Oxaprozin—Thrombocytopenia—Irinotecan—colon cancer	0.000435	0.00263	CcSEcCtD
Oxaprozin—Anorexia—Vincristine—colon cancer	0.000435	0.00263	CcSEcCtD
Oxaprozin—Phenylbutazone—PTGS2—colon cancer	0.000434	0.167	CrCbGaD
Oxaprozin—PTGS2—lymphoid tissue—colon cancer	0.00043	0.0305	CbGeAlD
Oxaprozin—Hyperhidrosis—Irinotecan—colon cancer	0.000429	0.0026	CcSEcCtD
Oxaprozin—Confusional state—Fluorouracil—colon cancer	0.000429	0.0026	CcSEcCtD
Oxaprozin—Hypotension—Vincristine—colon cancer	0.000426	0.00258	CcSEcCtD
Oxaprozin—Anaphylactic shock—Fluorouracil—colon cancer	0.000425	0.00257	CcSEcCtD
Oxaprozin—Oedema—Fluorouracil—colon cancer	0.000425	0.00257	CcSEcCtD
Oxaprozin—PTGS2—digestive system—colon cancer	0.000424	0.0302	CbGeAlD
Oxaprozin—Anorexia—Irinotecan—colon cancer	0.000423	0.00256	CcSEcCtD
Oxaprozin—Infection—Fluorouracil—colon cancer	0.000423	0.00256	CcSEcCtD
Oxaprozin—Haemoglobin—Capecitabine—colon cancer	0.00042	0.00255	CcSEcCtD
Oxaprozin—Hepatitis—Capecitabine—colon cancer	0.000418	0.00253	CcSEcCtD
Oxaprozin—Haemorrhage—Capecitabine—colon cancer	0.000418	0.00253	CcSEcCtD
Oxaprozin—Thrombocytopenia—Fluorouracil—colon cancer	0.000416	0.00252	CcSEcCtD
Oxaprozin—Tachycardia—Fluorouracil—colon cancer	0.000415	0.00251	CcSEcCtD
Oxaprozin—Hypotension—Irinotecan—colon cancer	0.000415	0.00251	CcSEcCtD
Oxaprozin—Insomnia—Vincristine—colon cancer	0.000412	0.0025	CcSEcCtD
Oxaprozin—Paraesthesia—Vincristine—colon cancer	0.000409	0.00248	CcSEcCtD
Oxaprozin—Anorexia—Fluorouracil—colon cancer	0.000405	0.00245	CcSEcCtD
Oxaprozin—Toxic epidermal necrolysis—Methotrexate—colon cancer	0.000405	0.00245	CcSEcCtD
Oxaprozin—Insomnia—Irinotecan—colon cancer	0.000402	0.00243	CcSEcCtD
Oxaprozin—Paraesthesia—Irinotecan—colon cancer	0.000399	0.00241	CcSEcCtD
Oxaprozin—Hypotension—Fluorouracil—colon cancer	0.000397	0.00241	CcSEcCtD
Oxaprozin—Decreased appetite—Vincristine—colon cancer	0.000396	0.0024	CcSEcCtD
Oxaprozin—Dyspnoea—Irinotecan—colon cancer	0.000396	0.0024	CcSEcCtD
Oxaprozin—Erythema multiforme—Capecitabine—colon cancer	0.000396	0.00239	CcSEcCtD
Oxaprozin—Somnolence—Irinotecan—colon cancer	0.000395	0.00239	CcSEcCtD
Oxaprozin—PTGS1—vagina—colon cancer	0.000392	0.0279	CbGeAlD
Oxaprozin—PTGS2—bone marrow—colon cancer	0.000391	0.0278	CbGeAlD
Oxaprozin—Dyspepsia—Irinotecan—colon cancer	0.000391	0.00237	CcSEcCtD
Oxaprozin—Tinnitus—Capecitabine—colon cancer	0.00039	0.00236	CcSEcCtD
Oxaprozin—Constipation—Vincristine—colon cancer	0.00039	0.00236	CcSEcCtD
Oxaprozin—Asthma—Methotrexate—colon cancer	0.000389	0.00236	CcSEcCtD
Oxaprozin—Decreased appetite—Irinotecan—colon cancer	0.000386	0.00234	CcSEcCtD
Oxaprozin—Eosinophilia—Methotrexate—colon cancer	0.000385	0.00233	CcSEcCtD
Oxaprozin—Insomnia—Fluorouracil—colon cancer	0.000385	0.00233	CcSEcCtD
Oxaprozin—Paraesthesia—Fluorouracil—colon cancer	0.000382	0.00231	CcSEcCtD
Oxaprozin—Pancreatitis—Methotrexate—colon cancer	0.000381	0.00231	CcSEcCtD
Oxaprozin—Constipation—Irinotecan—colon cancer	0.00038	0.0023	CcSEcCtD
Oxaprozin—Dyspnoea—Fluorouracil—colon cancer	0.000379	0.0023	CcSEcCtD
Oxaprozin—Somnolence—Fluorouracil—colon cancer	0.000378	0.00229	CcSEcCtD
Oxaprozin—PTGS2—vagina—colon cancer	0.000375	0.0266	CbGeAlD
Oxaprozin—Dyspepsia—Fluorouracil—colon cancer	0.000374	0.00227	CcSEcCtD
Oxaprozin—Arrhythmia—Capecitabine—colon cancer	0.000374	0.00226	CcSEcCtD
Oxaprozin—Gastrointestinal pain—Vincristine—colon cancer	0.000373	0.00226	CcSEcCtD
Oxaprozin—Decreased appetite—Fluorouracil—colon cancer	0.00037	0.00224	CcSEcCtD
Oxaprozin—Alopecia—Capecitabine—colon cancer	0.00037	0.00224	CcSEcCtD
Oxaprozin—Pancytopenia—Methotrexate—colon cancer	0.000369	0.00224	CcSEcCtD
Oxaprozin—Feeling abnormal—Irinotecan—colon cancer	0.000366	0.00222	CcSEcCtD
Oxaprozin—Dysuria—Methotrexate—colon cancer	0.000364	0.0022	CcSEcCtD
Oxaprozin—Gastrointestinal pain—Irinotecan—colon cancer	0.000363	0.0022	CcSEcCtD
Oxaprozin—CYP2C9—liver—colon cancer	0.000362	0.0258	CbGeAlD
Oxaprozin—Abdominal pain—Vincristine—colon cancer	0.00036	0.00218	CcSEcCtD
Oxaprozin—Body temperature increased—Vincristine—colon cancer	0.00036	0.00218	CcSEcCtD
Oxaprozin—Flatulence—Capecitabine—colon cancer	0.000359	0.00217	CcSEcCtD
Oxaprozin—Dysgeusia—Capecitabine—colon cancer	0.000357	0.00216	CcSEcCtD
Oxaprozin—Photosensitivity reaction—Methotrexate—colon cancer	0.000355	0.00215	CcSEcCtD
Oxaprozin—Flurbiprofen—PTGS2—colon cancer	0.000354	0.136	CrCbGaD
Oxaprozin—Abdominal pain—Irinotecan—colon cancer	0.000351	0.00213	CcSEcCtD
Oxaprozin—Body temperature increased—Irinotecan—colon cancer	0.000351	0.00213	CcSEcCtD
Oxaprozin—Feeling abnormal—Fluorouracil—colon cancer	0.00035	0.00212	CcSEcCtD
Oxaprozin—Pneumonia—Methotrexate—colon cancer	0.000349	0.00211	CcSEcCtD
Oxaprozin—Drowsiness—Methotrexate—colon cancer	0.000347	0.0021	CcSEcCtD
Oxaprozin—Propafenone—ABCB1—colon cancer	0.000345	0.133	CrCbGaD
Oxaprozin—Stevens-Johnson syndrome—Methotrexate—colon cancer	0.000344	0.00208	CcSEcCtD
Oxaprozin—Vision blurred—Capecitabine—colon cancer	0.000343	0.00208	CcSEcCtD
Oxaprozin—Tremor—Capecitabine—colon cancer	0.000341	0.00207	CcSEcCtD
Oxaprozin—Renal failure—Methotrexate—colon cancer	0.000341	0.00206	CcSEcCtD
Oxaprozin—Stomatitis—Methotrexate—colon cancer	0.000338	0.00205	CcSEcCtD
Oxaprozin—Ill-defined disorder—Capecitabine—colon cancer	0.000338	0.00205	CcSEcCtD
Oxaprozin—Urticaria—Fluorouracil—colon cancer	0.000338	0.00205	CcSEcCtD
Oxaprozin—Conjunctivitis—Methotrexate—colon cancer	0.000337	0.00204	CcSEcCtD
Oxaprozin—Anaemia—Capecitabine—colon cancer	0.000337	0.00204	CcSEcCtD
Oxaprozin—Body temperature increased—Fluorouracil—colon cancer	0.000336	0.00204	CcSEcCtD
Oxaprozin—Haematuria—Methotrexate—colon cancer	0.000331	0.002	CcSEcCtD
Oxaprozin—Malaise—Capecitabine—colon cancer	0.000328	0.00199	CcSEcCtD
Oxaprozin—Vertigo—Capecitabine—colon cancer	0.000327	0.00198	CcSEcCtD
Oxaprozin—Asthenia—Vincristine—colon cancer	0.000327	0.00198	CcSEcCtD
Oxaprozin—Syncope—Capecitabine—colon cancer	0.000327	0.00198	CcSEcCtD
Oxaprozin—Leukopenia—Capecitabine—colon cancer	0.000326	0.00197	CcSEcCtD
Oxaprozin—Agranulocytosis—Methotrexate—colon cancer	0.000324	0.00196	CcSEcCtD
Oxaprozin—Palpitations—Capecitabine—colon cancer	0.000322	0.00195	CcSEcCtD
Oxaprozin—Loss of consciousness—Capecitabine—colon cancer	0.00032	0.00194	CcSEcCtD
Oxaprozin—Asthenia—Irinotecan—colon cancer	0.000319	0.00193	CcSEcCtD
Oxaprozin—PTGS2—liver—colon cancer	0.000316	0.0225	CbGeAlD
Oxaprozin—Hypertension—Capecitabine—colon cancer	0.000314	0.0019	CcSEcCtD
Oxaprozin—Haemoglobin—Methotrexate—colon cancer	0.000313	0.0019	CcSEcCtD
Oxaprozin—Diarrhoea—Vincristine—colon cancer	0.000312	0.00189	CcSEcCtD
Oxaprozin—Haemorrhage—Methotrexate—colon cancer	0.000311	0.00189	CcSEcCtD
Oxaprozin—Hepatitis—Methotrexate—colon cancer	0.000311	0.00189	CcSEcCtD
Oxaprozin—Anxiety—Capecitabine—colon cancer	0.000309	0.00187	CcSEcCtD
Oxaprozin—Discomfort—Capecitabine—colon cancer	0.000306	0.00185	CcSEcCtD
Oxaprozin—Diarrhoea—Irinotecan—colon cancer	0.000304	0.00184	CcSEcCtD
Oxaprozin—Dry mouth—Capecitabine—colon cancer	0.000303	0.00184	CcSEcCtD
Oxaprozin—Dizziness—Vincristine—colon cancer	0.000302	0.00183	CcSEcCtD
Oxaprozin—Pruritus—Fluorouracil—colon cancer	0.000301	0.00182	CcSEcCtD
Oxaprozin—Confusional state—Capecitabine—colon cancer	0.0003	0.00181	CcSEcCtD
Oxaprozin—Oedema—Capecitabine—colon cancer	0.000297	0.0018	CcSEcCtD
Oxaprozin—Infection—Capecitabine—colon cancer	0.000295	0.00179	CcSEcCtD
Oxaprozin—Erythema multiforme—Methotrexate—colon cancer	0.000294	0.00178	CcSEcCtD
Oxaprozin—Dizziness—Irinotecan—colon cancer	0.000294	0.00178	CcSEcCtD
Oxaprozin—Shock—Capecitabine—colon cancer	0.000292	0.00177	CcSEcCtD
Oxaprozin—Diarrhoea—Fluorouracil—colon cancer	0.000291	0.00176	CcSEcCtD
Oxaprozin—Thrombocytopenia—Capecitabine—colon cancer	0.000291	0.00176	CcSEcCtD
Oxaprozin—Tinnitus—Methotrexate—colon cancer	0.00029	0.00176	CcSEcCtD
Oxaprozin—Tachycardia—Capecitabine—colon cancer	0.00029	0.00176	CcSEcCtD
Oxaprozin—Vomiting—Vincristine—colon cancer	0.00029	0.00176	CcSEcCtD
Oxaprozin—Rash—Vincristine—colon cancer	0.000288	0.00174	CcSEcCtD
Oxaprozin—Hyperhidrosis—Capecitabine—colon cancer	0.000287	0.00174	CcSEcCtD
Oxaprozin—Dermatitis—Vincristine—colon cancer	0.000287	0.00174	CcSEcCtD
Oxaprozin—Headache—Vincristine—colon cancer	0.000286	0.00173	CcSEcCtD
Oxaprozin—Anorexia—Capecitabine—colon cancer	0.000283	0.00172	CcSEcCtD
Oxaprozin—Vomiting—Irinotecan—colon cancer	0.000282	0.00171	CcSEcCtD
Oxaprozin—Dizziness—Fluorouracil—colon cancer	0.000281	0.0017	CcSEcCtD
Oxaprozin—Rash—Irinotecan—colon cancer	0.00028	0.0017	CcSEcCtD
Oxaprozin—Dermatitis—Irinotecan—colon cancer	0.00028	0.00169	CcSEcCtD
Oxaprozin—Headache—Irinotecan—colon cancer	0.000278	0.00168	CcSEcCtD
Oxaprozin—Hypotension—Capecitabine—colon cancer	0.000278	0.00168	CcSEcCtD
Oxaprozin—Alopecia—Methotrexate—colon cancer	0.000275	0.00167	CcSEcCtD
Oxaprozin—Nausea—Vincristine—colon cancer	0.000271	0.00164	CcSEcCtD
Oxaprozin—Vomiting—Fluorouracil—colon cancer	0.00027	0.00164	CcSEcCtD
Oxaprozin—Insomnia—Capecitabine—colon cancer	0.000269	0.00163	CcSEcCtD
Oxaprozin—Rash—Fluorouracil—colon cancer	0.000268	0.00162	CcSEcCtD
Oxaprozin—Dermatitis—Fluorouracil—colon cancer	0.000268	0.00162	CcSEcCtD
Oxaprozin—Paraesthesia—Capecitabine—colon cancer	0.000267	0.00162	CcSEcCtD
Oxaprozin—Headache—Fluorouracil—colon cancer	0.000266	0.00161	CcSEcCtD
Oxaprozin—Dysgeusia—Methotrexate—colon cancer	0.000265	0.00161	CcSEcCtD
Oxaprozin—Dyspnoea—Capecitabine—colon cancer	0.000265	0.0016	CcSEcCtD
Oxaprozin—Nausea—Irinotecan—colon cancer	0.000264	0.0016	CcSEcCtD
Oxaprozin—Carbamazepine—ABCB1—colon cancer	0.000264	0.101	CrCbGaD
Oxaprozin—Dyspepsia—Capecitabine—colon cancer	0.000262	0.00158	CcSEcCtD
Oxaprozin—Decreased appetite—Capecitabine—colon cancer	0.000258	0.00156	CcSEcCtD
Oxaprozin—Phenytoin—ABCB1—colon cancer	0.000256	0.0985	CrCbGaD
Oxaprozin—Vision blurred—Methotrexate—colon cancer	0.000255	0.00155	CcSEcCtD
Oxaprozin—Constipation—Capecitabine—colon cancer	0.000254	0.00154	CcSEcCtD
Oxaprozin—PTGS1—lymph node—colon cancer	0.000254	0.018	CbGeAlD
Oxaprozin—Nausea—Fluorouracil—colon cancer	0.000253	0.00153	CcSEcCtD
Oxaprozin—Ill-defined disorder—Methotrexate—colon cancer	0.000252	0.00152	CcSEcCtD
Oxaprozin—Anaemia—Methotrexate—colon cancer	0.000251	0.00152	CcSEcCtD
Oxaprozin—Feeling abnormal—Capecitabine—colon cancer	0.000245	0.00148	CcSEcCtD
Oxaprozin—Malaise—Methotrexate—colon cancer	0.000244	0.00148	CcSEcCtD
Oxaprozin—Vertigo—Methotrexate—colon cancer	0.000244	0.00147	CcSEcCtD
Oxaprozin—Gastrointestinal pain—Capecitabine—colon cancer	0.000243	0.00147	CcSEcCtD
Oxaprozin—Leukopenia—Methotrexate—colon cancer	0.000243	0.00147	CcSEcCtD
Oxaprozin—PTGS2—lymph node—colon cancer	0.000242	0.0172	CbGeAlD
Oxaprozin—Urticaria—Capecitabine—colon cancer	0.000236	0.00143	CcSEcCtD
Oxaprozin—Abdominal pain—Capecitabine—colon cancer	0.000235	0.00142	CcSEcCtD
Oxaprozin—Body temperature increased—Capecitabine—colon cancer	0.000235	0.00142	CcSEcCtD
Oxaprozin—Convulsion—Methotrexate—colon cancer	0.000235	0.00142	CcSEcCtD
Oxaprozin—Discomfort—Methotrexate—colon cancer	0.000228	0.00138	CcSEcCtD
Oxaprozin—Confusional state—Methotrexate—colon cancer	0.000223	0.00135	CcSEcCtD
Oxaprozin—Anaphylactic shock—Methotrexate—colon cancer	0.000221	0.00134	CcSEcCtD
Oxaprozin—Infection—Methotrexate—colon cancer	0.00022	0.00133	CcSEcCtD
Oxaprozin—Thrombocytopenia—Methotrexate—colon cancer	0.000217	0.00131	CcSEcCtD
Oxaprozin—Hyperhidrosis—Methotrexate—colon cancer	0.000214	0.00129	CcSEcCtD
Oxaprozin—Asthenia—Capecitabine—colon cancer	0.000213	0.00129	CcSEcCtD
Oxaprozin—Anorexia—Methotrexate—colon cancer	0.000211	0.00128	CcSEcCtD
Oxaprozin—Pruritus—Capecitabine—colon cancer	0.00021	0.00127	CcSEcCtD
Oxaprozin—Hypotension—Methotrexate—colon cancer	0.000207	0.00125	CcSEcCtD
Oxaprozin—Diarrhoea—Capecitabine—colon cancer	0.000203	0.00123	CcSEcCtD
Oxaprozin—Insomnia—Methotrexate—colon cancer	0.0002	0.00121	CcSEcCtD
Oxaprozin—Paraesthesia—Methotrexate—colon cancer	0.000199	0.0012	CcSEcCtD
Oxaprozin—Dyspnoea—Methotrexate—colon cancer	0.000197	0.00119	CcSEcCtD
Oxaprozin—Somnolence—Methotrexate—colon cancer	0.000197	0.00119	CcSEcCtD
Oxaprozin—Dizziness—Capecitabine—colon cancer	0.000197	0.00119	CcSEcCtD
Oxaprozin—Dyspepsia—Methotrexate—colon cancer	0.000195	0.00118	CcSEcCtD
Oxaprozin—Methadone—ABCB1—colon cancer	0.000194	0.0745	CrCbGaD
Oxaprozin—Decreased appetite—Methotrexate—colon cancer	0.000192	0.00116	CcSEcCtD
Oxaprozin—Vomiting—Capecitabine—colon cancer	0.000189	0.00114	CcSEcCtD
Oxaprozin—Rash—Capecitabine—colon cancer	0.000187	0.00113	CcSEcCtD
Oxaprozin—Dermatitis—Capecitabine—colon cancer	0.000187	0.00113	CcSEcCtD
Oxaprozin—Headache—Capecitabine—colon cancer	0.000186	0.00113	CcSEcCtD
Oxaprozin—Feeling abnormal—Methotrexate—colon cancer	0.000182	0.0011	CcSEcCtD
Oxaprozin—Gastrointestinal pain—Methotrexate—colon cancer	0.000181	0.0011	CcSEcCtD
Oxaprozin—Nausea—Capecitabine—colon cancer	0.000177	0.00107	CcSEcCtD
Oxaprozin—Urticaria—Methotrexate—colon cancer	0.000176	0.00106	CcSEcCtD
Oxaprozin—Abdominal pain—Methotrexate—colon cancer	0.000175	0.00106	CcSEcCtD
Oxaprozin—Body temperature increased—Methotrexate—colon cancer	0.000175	0.00106	CcSEcCtD
Oxaprozin—Asthenia—Methotrexate—colon cancer	0.000159	0.000961	CcSEcCtD
Oxaprozin—Pruritus—Methotrexate—colon cancer	0.000157	0.000948	CcSEcCtD
Oxaprozin—Diarrhoea—Methotrexate—colon cancer	0.000151	0.000917	CcSEcCtD
Oxaprozin—Dizziness—Methotrexate—colon cancer	0.000146	0.000886	CcSEcCtD
Oxaprozin—Vomiting—Methotrexate—colon cancer	0.000141	0.000852	CcSEcCtD
Oxaprozin—Rash—Methotrexate—colon cancer	0.00014	0.000845	CcSEcCtD
Oxaprozin—Dermatitis—Methotrexate—colon cancer	0.000139	0.000844	CcSEcCtD
Oxaprozin—Headache—Methotrexate—colon cancer	0.000139	0.000839	CcSEcCtD
Oxaprozin—Nausea—Methotrexate—colon cancer	0.000131	0.000796	CcSEcCtD
